Literature DB >> 80630

Mycobacteria as a possible cause of inflammatory bowel disease.

W R Burnham, J E Lennard-Jones, J L Stanford, R G Bird.   

Abstract

Mesenteric lymph-nodes from 27 patients with Crohn's disease, 13 with ulcerative colitis, and 11 without inflammatory bowel disease were cultured for mycobacteria. A node from a patient with Crohn's disease yielded a strain of Mycobacterium kansasii. Cultures from 22 other patients with Crohn's disease, 7 with ulcerative colitis, and 1 control subject yielded pleomorphic organisms with the electron-microscopic appearances of cell-wall-deficient organisms. Further culture and characterisation of these organisms has so far proved unsuccesful. Skin tests with tuberculin were positive in a smaller proportion of patients with Crohn's disease than in healthy control subjects. Conversely, the patients gave a higher proportion of positive reactions to a reagent prepared from the strain of M. kansasii isolated. No differences in the proportion of positive test were found between patients and controls with reagents prepared from 16 other mycobacteria. Cell-wall-deficient mycobacteria are a possible causative agent of inflammatory bowel disease.

Entities:  

Mesh:

Year:  1978        PMID: 80630     DOI: 10.1016/s0140-6736(78)92699-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

1.  Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization.

Authors:  L A Sechi; M Mura; F Tanda; A Lissia; A Solinas; G Fadda; S Zanetti; M Manuela; T Francesco; L Amelia; S Antonello; F Giovanni; Z Stefania
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 2.  Mycobacterial diseases of the gut: some impact from molecular biology.

Authors:  J D Sanderson; J Hermon-Taylor
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 3.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 4.  Pathology of Crohn's disease.

Authors:  B C Morson
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

Review 5.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

7.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Incidence of Crohn's disease in Cardiff between 1934-1977.

Authors:  J Mayberry; J Rhodes; L E Hughes
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

9.  Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization.

Authors:  H H Yoshimura; D Y Graham; M K Estes; R S Merkal
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease.

Authors:  W R Thayer; J A Coutu; R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.